1309 related articles for article (PubMed ID: 21704233)
21. Reducing cardiovascular disease risk in patients with type 2 diabetes and concomitant macrovascular disease: can insulin be too much of a good thing?
Rensing KL; Reuwer AQ; Arsenault BJ; von der Thüsen JH; Hoekstra JB; Kastelein JJ; Twickler TB
Diabetes Obes Metab; 2011 Dec; 13(12):1073-87. PubMed ID: 21736687
[TBL] [Abstract][Full Text] [Related]
22. Assessing cardiovascular risk factors and selecting agents to successfully treat patients with type 2 diabetes mellitus.
Baldwin MD
J Am Osteopath Assoc; 2011 Jul; 111(7 Suppl 5):S2-12. PubMed ID: 21813732
[TBL] [Abstract][Full Text] [Related]
23. In support of an early polypharmacy approach to the treatment of type 2 diabetes.
Wright EE; Stonehouse AH; Cuddihy RM
Diabetes Obes Metab; 2010 Nov; 12(11):929-40. PubMed ID: 20880339
[TBL] [Abstract][Full Text] [Related]
24. Effects of glucose-lowering and multifactorial interventions on cardiovascular and mortality outcomes: a meta-analysis of randomized control trials.
Seidu S; Achana FA; Gray LJ; Davies MJ; Khunti K
Diabet Med; 2016 Mar; 33(3):280-9. PubMed ID: 26282461
[TBL] [Abstract][Full Text] [Related]
25. Evaluating treatment algorithms for the management of patients with type 2 diabetes mellitus: a perspective on the definition of treatment success.
Aguilar RB
Clin Ther; 2011 Apr; 33(4):408-24. PubMed ID: 21635988
[TBL] [Abstract][Full Text] [Related]
26. Cardiovascular Protection in the Treatment of Type 2 Diabetes: A Review of Clinical Trial Results Across Drug Classes.
Paneni F; Lüscher TF
Am J Med; 2017 Jun; 130(6S):S18-S29. PubMed ID: 28526186
[TBL] [Abstract][Full Text] [Related]
27. Impact of diabetes mellitus and insulin use on survival after colorectal cancer diagnosis: the Cancer Prevention Study-II Nutrition Cohort.
Dehal AN; Newton CC; Jacobs EJ; Patel AV; Gapstur SM; Campbell PT
J Clin Oncol; 2012 Jan; 30(1):53-9. PubMed ID: 22124092
[TBL] [Abstract][Full Text] [Related]
28. [Is an intensive glycaemic control beneficial in diabetes type 2?].
Martin S
Dtsch Med Wochenschr; 2011 Sep; 136(39):1940. PubMed ID: 21948602
[No Abstract] [Full Text] [Related]
29. Intensive insulin regimens: evidence for benefit.
Bretzel RG
Int J Obes Relat Metab Disord; 2004 Sep; 28 Suppl 2():S8-13. PubMed ID: 15306832
[TBL] [Abstract][Full Text] [Related]
30. [Cardiovascular risk reduction in the management of diabetic patients: what has changed since the '90s in the clinical approach?].
Consoli A; Di Fulvio P
G Ital Cardiol (Rome); 2014 Dec; 15(12 Suppl 2):21S-26S. PubMed ID: 25623547
[TBL] [Abstract][Full Text] [Related]
31. Outcome studies in type 2 diabetes.
Hanefeld M
Curr Med Res Opin; 2005; 21 Suppl 1():S41-8. PubMed ID: 15811198
[TBL] [Abstract][Full Text] [Related]
32. Pharmacologic Management of Type 2 Diabetes Mellitus: Available Therapies.
Thrasher J
Am J Med; 2017 Jun; 130(6S):S4-S17. PubMed ID: 28526182
[TBL] [Abstract][Full Text] [Related]
33. The Role of Hypoglycemia in Cardiovascular Outcomes in Diabetes.
Paty BW
Can J Diabetes; 2015 Dec; 39 Suppl 5():S155-9. PubMed ID: 26654859
[TBL] [Abstract][Full Text] [Related]
34. Cardiovascular prevention in type 2 diabetic patients: review of efficacious treatments.
Goderis G; Boland B
Acta Clin Belg; 2004; 59(6):329-39. PubMed ID: 15819377
[TBL] [Abstract][Full Text] [Related]
35. Cardiovascular safety and glycemic control of glucagon-like peptide-1 receptor agonists for type 2 diabetes mellitus: a pairwise and network meta-analysis.
Sun F; Yu K; Wu S; Zhang Y; Yang Z; Shi L; Ji L; Zhan S
Diabetes Res Clin Pract; 2012 Dec; 98(3):386-95. PubMed ID: 23020934
[TBL] [Abstract][Full Text] [Related]
36. Hypoglycemic potential of current and emerging pharmacotherapies in type 2 diabetes mellitus.
Brunton SA
Postgrad Med; 2012 Jul; 124(4):74-83. PubMed ID: 22913896
[TBL] [Abstract][Full Text] [Related]
37. Clinical implications of the ACCORD trial.
Genuth S; Ismail-Beigi F
J Clin Endocrinol Metab; 2012 Jan; 97(1):41-8. PubMed ID: 22049171
[TBL] [Abstract][Full Text] [Related]
38. Metabolic memory: Evolving concepts.
Misra A; Bloomgarden Z
J Diabetes; 2018 Mar; 10(3):186-187. PubMed ID: 29091343
[TBL] [Abstract][Full Text] [Related]
39. [Glucocentricity or adipocentricity: a critical view of consensus and clinical guidelines for the treatment of type 2 diabetes mellitus].
Gorgojo Martínez JJ
Endocrinol Nutr; 2011 Dec; 58(10):541-9. PubMed ID: 22094149
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
